Bleomycin for Injection USP: Glass Particulate
Brand(s)
Last updated
Summary
Product
Bleomycin for Injection USP
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Bleomycin for Injection USP | Bleomycin for Injection USP | DIN 02131692 | Powder for Solution | Bleomycin (Bleomycin Sulfate) 15 unit/vial | BL12206B |
Issue
Affected lot may contain glass particulate.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishment
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pfizer Canada ULC
17300 Route Transcanadienne
Kirkland, Quebec
H9J 2M5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-74786
Get notified
Receive notifications for new and updated recalls and alerts by category.